ARQ Wealth Advisors LLC Takes $865,000 Position in Kenvue Inc. $KVUE

ARQ Wealth Advisors LLC bought a new stake in Kenvue Inc. (NYSE:KVUE) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 50,175 shares of the company’s stock, valued at approximately $865,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Montag A & Associates Inc. lifted its position in shares of Kenvue by 6.3% in the first quarter. Montag A & Associates Inc. now owns 10,156 shares of the company’s stock valued at $175,000 after buying an additional 600 shares during the last quarter. Cornerstone Wealth Group LLC increased its holdings in shares of Kenvue by 5.9% during the 1st quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company’s stock worth $187,000 after acquiring an additional 606 shares during the last quarter. Physician Wealth Advisors Inc. increased its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after acquiring an additional 618 shares during the last quarter. Mill Creek Capital Advisors LLC raised its stake in Kenvue by 0.6% in the 4th quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock valued at $2,143,000 after acquiring an additional 701 shares during the period. Finally, B & T Capital Management DBA Alpha Capital Management lifted its holdings in Kenvue by 0.3% during the 4th quarter. B & T Capital Management DBA Alpha Capital Management now owns 234,664 shares of the company’s stock valued at $4,048,000 after purchasing an additional 712 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Citigroup reduced their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Barclays decreased their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. UBS Group lowered their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Finally, Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $19.33.

Kenvue Stock Performance

Shares of Kenvue stock traded up $0.32 during trading on Friday, reaching $19.50. The company’s stock had a trading volume of 9,451,469 shares, compared to its average volume of 18,740,484. The business’s 50-day moving average price is $18.06 and its 200-day moving average price is $17.79. The firm has a market cap of $37.43 billion, a PE ratio of 22.94, a P/E/G ratio of 1.48 and a beta of 0.47. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $22.87. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same period last year, the firm earned $0.24 earnings per share. Kenvue’s revenue for the quarter was up 4.5% compared to the same quarter last year. Equities analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.3%. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.59% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.